A series of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines was shown to exhibit 5-HT2C agonist binding and functional activity. Compound 21R inhibited food intake over 2 h in fasted, male Sprague Dawley rats with ED50 values of 2 mg/kg (i.p.) and 10 mg/kg (p.o.).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(00)00400-5 | DOI Listing |
Publication Analysis
Top Keywords
2344a-tetrahydro-1h-pyrazino[12-a]quinoxalin-5-6hones 2344a56-hexahydro-1h-pyrazino[12-a]quinoxalines
8
synthesis 5-hydroxytryptamine
4
5-hydroxytryptamine 5-ht
4
5-ht activity
4
activity 2344a-tetrahydro-1h-pyrazino[12-a]quinoxalin-5-6hones
4
2344a56-hexahydro-1h-pyrazino[12-a]quinoxalines series
4
series 2344a-tetrahydro-1h-pyrazino[12-a]quinoxalin-5-6hones
4
2344a56-hexahydro-1h-pyrazino[12-a]quinoxalines exhibit
4
exhibit 5-ht2c
4
5-ht2c agonist
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!